Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

dc.contributor.author	Filin I.Y.
dc.contributor.author	Kitaeva K.V.
dc.contributor.author	Rutland C.S.
dc.contributor.author	Rizvanov A.A.
dc.contributor.author	Solovyeva V.V.
dc.date.accessioned	2022-02-09T20:44:05Z
dc.date.available	2022-02-09T20:44:05Z
dc.date.issued	2021
dc.identifier.uri	https://dspace.kpfu.ru/xmlui/handle/net/169904
dc.description.abstract	The development of immunotherapeutic methods for the treatment of oncological diseases have made it possible to improve the effectiveness of standard therapies. There was no breakthrough after first using of personalized therapeutic vaccines based on dendritic cells in clinical practice. A deeper study of the biology of dendritic cells, as well as the use of new approaches and agents for antigenic work, have made it possible to expand the field of application of dendritic cell (DC) vaccines and improve the indicators of cancer patients. In addition, the low toxicity of DC vaccines in clinical trials makes it possible to use promising predictions of their applicability in wider clinical practice. This review examines new approaches and recent advances of the DC vaccine in clinical trials.
dc.subject	antigen-presenting cells
dc.subject	antitumor vaccines
dc.subject	cancer
dc.subject	dendritic cells
dc.subject	immunotherapy
dc.title	Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
dc.type	Review
dc.relation.ispartofseries-volume	11
dc.collection	Публикации сотрудников КФУ
dc.source.id	SCOPUS-2021-11-SID85116562916

Файлы в этом документе

Имя: SCOPUS-2021-11-SI ...

Размер: 56.16Kb

Формат: PDF

Публикации сотрудников КФУ Scopus [24551]
Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.